Is high dose vitamin D harmful?

Calcified Tissue International

Volumn 92, Issue 2, 2013, Pages 191-206

  Sanders, Kerrie M ^a   Nicholson, Geoffrey C ^a,b   Ebeling, Peter R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Age; Aging; Fractures; Osteoporosis; Steroid hormones; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PLACEBO; VITAMIN D;

ARTICLE; CLINICAL PRACTICE; DIETARY INTAKE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DRUG SAFETY; FALLING; FRACTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; LIQUID CHROMATOGRAPHY; LOADING DRUG DOSE; LOW DRUG DOSE; OBSERVATIONAL STUDY; OSTEOPOROSIS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK REDUCTION; SIDE EFFECT; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84873709229     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9679-1     Document Type: Article

References (83)

1. Mithal A, Wahl D, Bonjour J, Burckhardt P, Dawson-Hughes B, Eisman J et al (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807-1820
2. Nowson C, McGrath J, Ebeling P, Haikerwal A, Daly R, Sanders K et al (2012) Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 196(11):686-687
3. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE et al (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21(7):1151-1154
4. Henry HL, Bouillon R, Norman AW, Gallagher JC, Lips P, Heaney RP et al (2010) 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 121(1-2):4-6
5. Heaney RP, Holick MF (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26(3):455-457
6. Ebeling PR (2005) Megadose therapy for vitamin D deficiency. Med J Aust 183(1):4-5
7. Tang B, Eslick G, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370(9588):657-1656
8. Giusti A, Barone A, Pioli G, Girasole G, Razzano M, Pizzonia M et al (2010) Heterogeneity in serum 25-hydroxyvitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency. J Am Geriatr Soc 58:1489-1495
9. Leidig-Bruckner G, Roth H, Bruckner T, Lorenz A, Raue F, Frank-Raue K (2011) Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels - an observational study during clinical practice conditions. Osteoporos Int 22:231-240
10. Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J et al (2009) Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) 183:1-420
11. Hansen KE (2011) High-dose vitamin D: helpful or harmful? Curr Rheumatol Rep 13(3):257-264
12. Holick M (2007) Medical progress: vitamin D deficiency. N Engl J Med 357:266-281
13. Committee to Review Dietary Reference Intakes for Calcium and Vitamin D, Food and Nutrition Board (2010) Dietary reference intakes for calcium and vitamin D. Institute of Medicine, Washington, DC
14. Lips P, Bouillon R, van Schoor NM, Vanderschueren D, Verschueren S, Kuchuk N et al (2010) Reducing fracture risk with calcium and vitamin D. Clin Endocrinol (Oxf) 73(3):277-285
15. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16(7):713-716
16. Heaney R (2008) Vitamin D: criteria for safety and efficacy. Nutr Rev 66(Suppl 2):s178-s181
17. 3 input exceeding the lowest observed adverse effect concentration. Am J Clin Nutr 73:288-294
18. Montero-Odasso M, Duque G (2005) Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med 26:203-219
19. Anderson P, May B, Morris H (2003) Vitamin D metabolism: new concepts and clinical implications. Clin Biochem Rev 24:13-26
20. Group DIPART (2010) Patient level pooled analysis of 68,500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 340:b5463
21. Elders P, Lips P, Netelenbos J, Van Grinkel F, Khoe E, Van der Vijgh W et al (1994) Long-term effect of calcium supplementation on bone loss in perimenopausal women. J Bone Miner Res 9:963-970
22. Reid I, Mason B, Horne A, Ames R, Reid H, Bava U et al (2006) Randomized controlled trial of calcium in healthy older women. Am J Med 119(9):777-785
23. Cipriani C, Romagnoli E, Scillitani A, Chiodini I, Clerio R, Carnevale V et al (2010) Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young people with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 95:4771-4777
24. 3 supplementation in the elderly. Osteoporos Int 20(8):1407-1415
25. Diamond T, Ho K, Rohl P, Meerkin M (2005) Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 183(1):10-12
26. Vieth R (2011) The pharmacology of vitamin D. In: Feldman D, Pike J, Adams J (eds) vitamin D. Academic Press, London, pp 1041-1066
27. Sanders K, Stuart A, Williamson E, Simpson J, Kotowicz M, Young D et al (2010) Annual high-dose oral vitamin D for falls and fractures in elderly women: a randomised, double-blind, placebo-controlled study. JAMA 303(18):1815-1822
28. Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C (2007) Effect of annual intramuscular vitamin D on fracture risk in elderly men and women - a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 46(12):1852-1857
29. Bischoff-Ferrari H, Willett W, Wong J, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293(18):2257-2264
30. Bischoff-Ferrari H, Willett W, Wong J, Stuck A, Staehelin H, Orav J et al (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169(6):551-561
31. Reid I, Bolland M, Grey A (2008) Effect of calcium supplementation on hip fractures. Osteoporos Int 19(8):1119-1123
32. Cranney A, Weiler H, O'Donnell S, Puil L (2008) Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 88(2):513S-519S
33. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53-58
34. Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almas B, Jorde R (2012) The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass - a randomized controlled 1-year trial. Osteoporos Int 23(1):201-211
35. 3 deficiency. Bone 45:747-749
36. Byrne P, Freaney R, McKenna M (1995) Vitamin D supplementation in the elderly: review of safety and effectiveness of different regimes. Calcif Tissue Int 56:518-520
37. Heaney R, Davies K, Chen T, Holick M, Barger-Lux M (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204-210
38. Binkley N, Gemar D, Engelke J, Gangnon R, Ramamurthy R, Krueger D et al (2011) Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab 96(4):981-988
39. Garland C, Garland F, Gorham E, Lipkin M, Newmark H, Mohr S et al (2006) The role of vitamin D in cancer prevention. Am J Public Health 96(2):252-261
40. Lin R, White J (2004) The pleiotropic actions of vitamin D. BioEssays 26(1):21-28
41. Evatt M (2010) Beyond vitamin status: is there a role for vitamin D in Parkinson disease? Arch Neurol 67(7):795-796
42. Grant W (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94(6):1867-1875
43. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI (2010) Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res 70(21):8587-8597
44. Vieth R (2004) Enzyme kinetics hypothesis to explain the U-shaped risk curve for prostate cancer vs. 25-hydroxyvitamin D in Nordic countries. Int J Cancer 111(3):468
45. Grant WB (2004) Geographic variation of prostate cancer mortality rates in the United States: implications for prostate cancer risk related to vitamin D. Int J Cancer 111(3):470-472
46. Trivedi D, Doll R, Khaw K (2003) Effect of four monthly oral vitamin D supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326(7387):469-475
47. Ilahi M, Armas L, Heaney R (2008) Pharmokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 87:688-691
48. 3 on bone turnover markers. Calcif Tissue Int 91:365-369
49. 3: is increased risk of fractures attributable to changes in bone turnover markers? In: ANZBMS/IOF JSBR annual scientific meeting, Gold Coast, Australia
50. Heikinheimo R (1992) Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51(2):105-110
51. Pasco J, Henry M, Kotowicz M, Sanders K, Seeman E, Pasco J et al (2004) Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 19(5):752-758
52. Dawson-Hughes B, Harris S (2010) High-dose vitamin D supplementation: too much of a good thing? JAMA 303(18):1861-1862
53. Ensrud K, Ewing S, Fredman L, Hochberg M, Cauley J, Hillier T et al (2010) Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab 95:5266-5273
54. Michaelsson K, Baron J, Snellman G, Gedeborg R, Bysberg L, Sundstrom J et al (2010) Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 92(4):841-848
55. McGrath J, Eyles D, Pedersen C, Ko P, Burne T et al (2010) Neonatal vitamin D status and risk of schizophrenia. Arch Gen Psychiatry 67(9):889-894
56. Lyons R, Johansen A, Brophy S, Newcombe R, Phillips C, Lervy B et al (2007) Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int 18(6):811-818
57. 3 and mental well-being: vital D study. Br J Psychiatry 198:357-364
58. 3 blunts parathyroid hormone induction of kidney 1-hydroxylase. Arch Biochem Biophys 319(2):535-539
59. Vieth R (2009) Proposal A: optimal health requires high 25OHD levels >40 ng/ml (>100 nmol/L). Fourteenth Workshop on Vitamin D. Brugge, Belgium, p 72
60. 3 administered once a year: is the increased risk of falls attributable to changes in muscle strength? American Society of Bone and Mineral Research scientific meeting. San Diego, CA, September 16-20
61. Reid IR (2010) Vitamin D - let's get back to the evidence base. IBMS Bonekey 7(7):249-253
62. Buell JS, Dawson-Hughes B (2008) Vitamin D and neurocognitive dysfunction: preventing "D"ecline? Mol Aspects Med 29(6):415-422
63. Glendenning P, Zhu K, Inderjeeth C, Howat P, Lewis JR, Prince RL (2012) Effects of three-monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: a randomized controlled trial. J Bone Miner Res 27(1):170-176
64. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL (2011) Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 22(3):859-871
65. Cummings S (2010) A single, annual, high dose of oral vitamin D increased falls and fractures in older women. ACP J Club 153(3):JC3-3
66. Byers T (2010) Anticancer vitamins du jour - the ABCED's so far. Am J Epidemiol 172(1):1-3
67. World Cancer Research Fund, American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC
68. Francis R (2007) The vitamin D paradox. Rheumatology 46:1749-1750
69. Bouillon R, Norman AW, Lips P (2007) Vitamin D deficiency. N Engl J Med 357(19):1980-1981
70. Premaor MO, Scalco R, da Silva MJ, Froehlich PE, Furlanetto TW (2008) The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. J Bone Miner Metab 26(6):603-608
71. Pekkarinen T, Valimaki VV, Aarum S, Turpeinen U, Hamalainen E, Loyttyniemi E et al (2010) The same annual dose of 292000 IU of vitamin D (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D concentrations and renal function. Clin Endocrinol (Oxf) 72(4):455-461
72. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K (2008) Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 264:599-609
73. 3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 3:8
74. Law M, Withers H, Morris J, Anderson F (2006) Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 35:482-486
75. Aloia J, Bojadzievski T, Yusupov E, Shadzad G, Pollack S, Mikhail M et al (2010) The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial desigin. J Clin Endocrinol Metab 95(7):3216-3224
76. Chen W, Dawsey SM, Qiao YL, Mark SD, Dong ZW, Taylor PR et al (2007) Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer 97(1):123-128
77. Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N et al (2008) Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 100(11):796-804
78. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108(1):104-108
79. Stolzenberg-Solomon R, Vieth R, Azad A, Pietinen P, Taylor P, Virtamo J et al (2006) A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 66(20):10213-10219
80. Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT (2009) Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res 69(4):1439-1447
81. Flicker L, Mead K, MacInnis R, Nowson C, Scherer S, Stein M et al (2003) Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 51(11):1533-1538
82. 2 followed by intranasal insulin in Alzheimer's disease. J Alzheimers Dis 26(3):477-484
83. Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stahelin HB, Willett WC et al (2010) Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med 170(9):813-820